BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu M, Luo X, Li N, Chen H, Dai M. Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis. Clin Epidemiol 2019;11:943-54. [PMID: 31695506 DOI: 10.2147/CLEP.S213677] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ribbing Wilén H, Saraste D, Blom J. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test. J Med Screen 2022;:9691413221085218. [PMID: 35257615 DOI: 10.1177/09691413221085218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nasir Kansestani A, Zare ME, Tong Q, Zhang J. Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis. Sci Rep 2022;12:2623. [PMID: 35173276 DOI: 10.1038/s41598-022-06689-4] [Reference Citation Analysis]
3 Bretagne JF, Carlo A, Piette C, Rousseau C, Cosson M, Lièvre A. Significant decrease in interval colorectal cancer incidence after implementing immunochemical testing in a multiple-round guaiac-based screening programme. Br J Cancer 2021;125:1494-502. [PMID: 34511603 DOI: 10.1038/s41416-021-01546-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lu M, Wang L, Zhang Y, Liu C, Lu B, Du L, Liao X, Dong D, Wei D, Gao Y, Shi J, Ren J, Chen H, Dai M. Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening. Clin Transl Gastroenterol 2021;12:e00398. [PMID: 34397041 DOI: 10.14309/ctg.0000000000000398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ibáñez-Sanz G, Sanz-Pamplona R, Garcia M, On Behalf Of The Msic-Sc Research Group. Future Prospects of Colorectal Cancer Screening: Characterizing Interval Cancers. Cancers (Basel) 2021;13:1328. [PMID: 33809520 DOI: 10.3390/cancers13061328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Krinsky DL. Chapter 48: Home Testing and Monitoring Devices. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition 2020. [DOI: 10.21019/9781582123172.ch48] [Reference Citation Analysis]
7 Cariou M, El Fettouhi A, Kermarrec T, Bommelaere F, Foll Y, Nousbaum JB, Robaszkiewicz M, Quénéhervé L. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. Cancer Epidemiol 2020;69:101839. [PMID: 33096500 DOI: 10.1016/j.canep.2020.101839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]